Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Advanced Medical Solutions Group plc

Healthcare GB AMS

216.5GBX
2.50(1.17%)

Last update at 2026-06-03T15:35:00Z

Day Range

205.00216.57
LowHigh

52 Week Range

164.75248.50
LowHigh

Fundamentals

  • Previous Close 214.00
  • Market Cap439.30M
  • Volume816289
  • P/E Ratio40.60
  • Dividend Yield1.47%
  • EBITDA46.82M
  • Revenue TTM228.94M
  • Revenue Per Share TTM1.06
  • Gross Profit TTM 122.14M
  • Diluted EPS TTM0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 17.78M 9.82M 21.16M 25.91M 21.98M
Minority interest - -0.04800M 0.00000M - -
Net income 9.95M 7.09M 15.89M 20.41M 17.48M
Selling general administrative - 69.03M 50.67M 47.38M 36.97M
Selling and marketing expenses - 2.35M 1.52M 1.63M 1.48M
Gross profit 108.78M 82.77M 70.14M 73.42M 61.07M
Reconciled depreciation - 16.30M 10.79M 8.84M 8.85M
Ebit 21.99M 13.38M 20.61M 24.89M 23.00M
Ebitda 43.39M 29.68M 31.40M 35.42M 31.93M
Depreciation and amortization 21.40M 16.30M 10.79M 10.54M 8.93M
Non operating income net other - - - - -
Operating income 21.99M 10.45M 18.88M 24.89M 23.00M
Other operating expenses 206.94M 167.07M 107.33M 99.44M 85.60M
Interest expense 5.09M 3.56M 0.38M 0.67M 1.10M
Tax provision - 2.68M 5.27M 5.50M 4.50M
Interest income - 1.29M 2.47M 1.69M 0.08M
Net interest income - -2.26400M 2.09M 1.02M -1.01400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 7.69M 2.68M 5.27M 5.50M 4.50M
Total revenue 228.94M 177.52M 126.21M 124.33M 108.60M
Total operating expenses 86.79M 81.40M 51.26M 48.53M 38.07M
Cost of revenue 120.16M 84.90M 56.07M 50.91M 47.53M
Total other income expense net -4.20800M -0.63100M 2.27M 1.02M -1.01400M
Discontinued operations - - - - -
Net income from continuing ops - 7.14M 15.89M 20.41M 17.48M
Net income applicable to common shares - - - 20.41M 17.48M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 394.77M 389.00M 289.17M 281.09M 249.51M
Intangible assets - 97.41M 55.86M 48.37M 40.96M
Earning assets - - - - -
Other current assets 1.21M 0.30M 3.83M 21.74M 22.71M
Total liab 134.67M 147.48M 44.97M 44.47M 36.83M
Total stockholder equity 258.79M 240.78M 244.20M 236.62M 212.68M
Deferred long term liab - - - - 10.48M
Other current liab 4.29M -1.04600M 11.86M 0.95M 0.90M
Common stock 10.98M 10.89M 10.87M 10.84M 10.80M
Capital stock - 10.89M 10.87M 10.84M 10.80M
Retained earnings 184.64M 180.47M 178.53M 167.42M 151.35M
Other liab - - - 13.10M 11.12M
Good will - 116.88M 80.44M 70.86M 66.03M
Other assets - 0.00000M - 0.94M 10.58M
Cash 18.02M 17.04M 60.16M 82.26M 72.97M
Cash and equivalents - - - - -
Total current liabilities 49.95M 44.33M 21.58M 22.68M 17.01M
Current deferred revenue - - -1.16400M - -
Net debt 63.51M 72.61M -51.02300M -72.51200M -63.10500M
Short term debt 14.70M 11.60M 2.33M 1.06M 1.15M
Short long term debt - 5.42M 0.00000M - -
Short long term debt total 81.52M 89.65M 9.14M 9.75M 9.86M
Other stockholder equity 37.84M 32.18M 32.13M 58.36M 50.52M
Property plant equipment - - - 29.02M 27.44M
Total current assets 139.37M 126.28M 122.32M 131.91M 114.97M
Long term investments - - - - -
Net tangible assets - - - 117.39M 116.16M
Short term investments - - - - -
Net receivables 50.09M 53.68M 22.29M 21.55M 22.71M
Long term debt - 67.43M 0.00000M - -
Inventory 70.05M 55.26M 36.05M 27.91M 19.30M
Accounts payable 30.95M 33.78M 6.23M 20.67M 14.96M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 25.33M 17.23M 22.68M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.50M 0.59M 0.94M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 255.40M 262.72M 166.85M 149.18M 134.54M
Capital lease obligations - 13.71M 9.14M 9.75M 9.86M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -67.14900M -20.26500M -11.87900M -6.32600M
Change to liabilities - - - 1.71M 2.10M
Total cashflows from investing activities -13.53800M -67.14900M -20.26500M -11.87900M -6.32600M
Net borrowings - 17.26M -0.48000M -1.62600M -1.28100M
Total cash from financing activities -14.92300M 5.48M -13.61800M -6.32100M -5.10500M
Change to operating activities - - - - -
Net income 9.95M 7.09M 15.89M 24.89M 23.00M
Change in cash 0.98M -43.12100M -22.10200M 9.30M 19.14M
Begin period cash flow 17.04M 60.16M 82.26M 72.97M 53.83M
End period cash flow 18.02M 17.04M 60.16M 82.26M 72.97M
Total cash from operating activities 28.75M 19.49M 12.35M 26.88M 31.02M
Issuance of capital stock - 0.01M 0.18M 0.66M 1.09M
Depreciation 21.40M 16.30M 10.79M 8.84M 8.85M
Other cashflows from investing activities - 1.23M -3.79300M 0.82M 0.08M
Dividends paid 5.79M 5.20M 4.78M 4.34M 3.85M
Change to inventory -13.26700M -0.00200M -8.06400M -7.08700M 0.94M
Change to account receivables 5.04M -10.38400M -2.51500M -0.59600M -1.76900M
Sale purchase of stock - 0.00000M -6.71000M -0.39200M -0.36600M
Other cashflows from financing activities -3.88500M -6.59400M -1.83400M -1.91200M -1.61500M
Change to netincome - - - 3.60M 3.42M
Capital expenditures 7.36M 4.06M 9.85M 9.96M 6.46M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -10.27900M -6.06800M -15.82800M -5.97200M 1.28M
Stock based compensation - 3.09M 2.92M 2.44M 1.98M
Other non cash items 7.68M 2.16M -1.42000M -3.32400M -4.07700M
Free cash flow 21.39M 12.67M 2.50M 16.91M 24.56M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AMS
Advanced Medical Solutions Group plc		 2.50 1.17% 216.50 40.60 16.84 1.92 1.66 2.16 11.16
CTEC
ConvaTec Group PLC		 3.80 1.95% 198.70 37.27 14.66 1.79 3.77 2.94 13.89
TSTL
Tristel		 -2.5 0.65% 380.00 23.75 19.08 3.68 5.29 3.43 13.18
SPEC
Inspecs Group plc		 - -% 84.50 - 16.16 0.43 0.95 0.62 7.94
BVC
Batm Advanced Communications Ltd		 0.17 1.32% 13.40 - 39.53 0.36 0.90 0.37 2.44

Reports Covered

Stock Research & News

View All

Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

Advanced Medical Solutions Group plc

Premier Park, Winsford, United Kingdom, CW7 3RT

Key Executives

Name Title Year Born
Mr. Andrew Christopher Meredith BSc (Hons) CEO & Exec. Director 1967
Mr. Edward Johnson ACA CFO & Exec. Director 1972
Mr. Alan Richardson Chief Operations Officer NA
Ms. Cathy Tomlinson Group HR Director NA
Mr. Brian Dowd Head of US Commercial Team NA
Mr. Owen Bromley Company Sec. NA
Mr. Andrew Christopher Meredith BSc (Hons) CEO & Executive Director 1966
Mr. Edward Johnson ACA CFO, ESG Lead & Executive Director 1972
Mr. Michael Edward King Investor Relations Manager NA
Simon Swain Head of Legal NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions